Is eClinicalTouch 4 Legit & Safe?
With 4.2 stars across 1,120 ratings, eClinicalTouch 4 is an established app on the App Store. The 1-3 star reviews below show the specific issues some users hit, not red flags about the app itself.
Based on public App Store data and user reviews. Not affiliated with eClinicalWorks LLC.
What users complain about in eClinicalTouch 4
Users report that eClinicalTouch 4 is frustrating to use due to a clunky, inefficient interface with too many steps for basic tasks like prescribing medications. Many complain about severe battery drain, frequent crashes, and slow performance, especially on iPads. The latest updates are widely criticized for making the app slower and less functional compared to previous versions.
Summarized from 45 recent 1-3 star reviews.
eClinicalTouch 4: frequently asked questions
Is eClinicalTouch 4 legit?
eClinicalTouch 4 is a legitimate app listed on the App Store with a 4.2 star rating from 1,120 ratings. "Legit" and "good for you" are different questions: the 1-3 star reviews below show where real users run into trouble.
Is eClinicalTouch 4 safe to download?
eClinicalTouch 4 is distributed through the official App Store, which screens apps before listing. The main safety questions for most users are around subscriptions, data permissions, and billing. The negative reviews below surface those concerns when users report them.
Is eClinicalTouch 4 a scam?
eClinicalTouch 4 is a real, store-listed app rather than a scam link. As with any app, scan the negative reviews below for billing or subscription complaints so there are no surprises after install.
Why does eClinicalTouch 4 have negative reviews?
Even well-rated apps collect 1-3 star reviews when users hit specific friction: crashes, paywalls, account issues, or missing features. The reviews below group these complaints so you can judge whether they affect your use case.
Should I download eClinicalTouch 4?
For most users, eClinicalTouch 4 is a safe choice given its 4.2 star rating. Skim the negative reviews below to check the edge cases (regional limits, payment methods) that the high average hides.